493 related articles for article (PubMed ID: 17569509)
1. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.
Yang M; Culhane JC; Szewczuk LM; Jalili P; Ball HL; Machius M; Cole PA; Yu H
Biochemistry; 2007 Jul; 46(27):8058-65. PubMed ID: 17569509
[TBL] [Abstract][Full Text] [Related]
2. trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.
Schmidt DM; McCafferty DG
Biochemistry; 2007 Apr; 46(14):4408-16. PubMed ID: 17367163
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.
Mimasu S; Sengoku T; Fukuzawa S; Umehara T; Yokoyama S
Biochem Biophys Res Commun; 2008 Feb; 366(1):15-22. PubMed ID: 18039463
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.
Yang M; Culhane JC; Szewczuk LM; Gocke CB; Brautigam CA; Tomchick DR; Machius M; Cole PA; Yu H
Nat Struct Mol Biol; 2007 Jun; 14(6):535-9. PubMed ID: 17529991
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.
Yang M; Gocke CB; Luo X; Borek D; Tomchick DR; Machius M; Otwinowski Z; Yu H
Mol Cell; 2006 Aug; 23(3):377-87. PubMed ID: 16885027
[TBL] [Abstract][Full Text] [Related]
6. Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 .
Mimasu S; Umezawa N; Sato S; Higuchi T; Umehara T; Yokoyama S
Biochemistry; 2010 Aug; 49(30):6494-503. PubMed ID: 20568732
[TBL] [Abstract][Full Text] [Related]
7. Development and Structural Evaluation of N-Alkylated trans-2-Phenylcyclopropylamine-Based LSD1 Inhibitors.
Niwa H; Sato S; Handa N; Sengoku T; Umehara T; Yokoyama S
ChemMedChem; 2020 May; 15(9):787-793. PubMed ID: 32166890
[TBL] [Abstract][Full Text] [Related]
8. Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.
Binda C; Valente S; Romanenghi M; Pilotto S; Cirilli R; Karytinos A; Ciossani G; Botrugno OA; Forneris F; Tardugno M; Edmondson DE; Minucci S; Mattevi A; Mai A
J Am Chem Soc; 2010 May; 132(19):6827-33. PubMed ID: 20415477
[TBL] [Abstract][Full Text] [Related]
9. Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.
Zhu Q; Liu C; Ge Z; Fang X; Zhang X; Strååt K; Björkholm M; Xu D
PLoS One; 2008 Jan; 3(1):e1446. PubMed ID: 18197256
[TBL] [Abstract][Full Text] [Related]
10. New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin.
Forneris F; Battaglioli E; Mattevi A; Binda C
FEBS J; 2009 Aug; 276(16):4304-12. PubMed ID: 19624733
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
Shi Y; Lan F; Matson C; Mulligan P; Whetstine JR; Cole PA; Casero RA; Shi Y
Cell; 2004 Dec; 119(7):941-53. PubMed ID: 15620353
[TBL] [Abstract][Full Text] [Related]
12. A mechanism-based inactivator for histone demethylase LSD1.
Culhane JC; Szewczuk LM; Liu X; Da G; Marmorstein R; Cole PA
J Am Chem Soc; 2006 Apr; 128(14):4536-7. PubMed ID: 16594666
[TBL] [Abstract][Full Text] [Related]
13. Trans-2-phenylcyclopropylamine induces nerve cells apoptosis in zebrafish mediated by depression of LSD1 activity.
Jie Z; Li T; Jia-Yun H; Qiu J; Ping-Yao Z; Houyan S
Brain Res Bull; 2009 Aug; 80(1-2):79-84. PubMed ID: 19410636
[TBL] [Abstract][Full Text] [Related]
14. Human histone demethylase LSD1 reads the histone code.
Forneris F; Binda C; Vanoni MA; Battaglioli E; Mattevi A
J Biol Chem; 2005 Dec; 280(50):41360-5. PubMed ID: 16223729
[TBL] [Abstract][Full Text] [Related]
15. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.
Schulte JH; Lim S; Schramm A; Friedrichs N; Koster J; Versteeg R; Ora I; Pajtler K; Klein-Hitpass L; Kuhfittig-Kulle S; Metzger E; Schüle R; Eggert A; Buettner R; Kirfel J
Cancer Res; 2009 Mar; 69(5):2065-71. PubMed ID: 19223552
[TBL] [Abstract][Full Text] [Related]
16. Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitors.
Kakizawa T; Ota Y; Itoh Y; Suzuki T
Bioorg Med Chem Lett; 2018 Jan; 28(2):167-169. PubMed ID: 29198865
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure and mechanism of human lysine-specific demethylase-1.
Stavropoulos P; Blobel G; Hoelz A
Nat Struct Mol Biol; 2006 Jul; 13(7):626-32. PubMed ID: 16799558
[TBL] [Abstract][Full Text] [Related]
18. Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.
Dai XJ; Liu Y; Xiong XP; Xue LP; Zheng YC; Liu HM
J Med Chem; 2020 Dec; 63(23):14197-14215. PubMed ID: 32931269
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation.
Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M
Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860
[TBL] [Abstract][Full Text] [Related]
20. Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B.
Gooden DM; Schmidt DM; Pollock JA; Kabadi AM; McCafferty DG
Bioorg Med Chem Lett; 2008 May; 18(10):3047-51. PubMed ID: 18242989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
